Guo L-H, Schluesener H J
Institute of Brain Research, University of Tuebingen, Calwer Str.3, 72076 Tuebingen, Germany.
Cell Mol Life Sci. 2007 May;64(9):1128-36. doi: 10.1007/s00018-007-6494-3.
Toll-like receptors (TLRs) are a family of pattern recognition receptors that mediate innate immune responses to stimuli from pathogens or endogenous signals. Under various pathological conditions, the central nervous system (CNS) mounts a well-organized innate immune response, in which glial cells, in particular microglia, are activated. Further, the innate immune system has emerged as a promising target for therapeutic control of development and persistence of chronic pain. Especially, microglial cells respond to peripheral and central infection, injury, and other stressor signals arriving at the CNS and initiate a CNS immune activation that might contribute to chronic pain facilitation. In the orchestration of this limited immune reaction, TLRs on microglia appear to be most relevant in triggering and tailoring microglial activation, which might be a driving force of chronic pain. New therapeutic approaches targeting the CNS innate immune system may achieve the essential pharmacological control of chronic pain.
Toll样受体(TLRs)是一类模式识别受体,介导对病原体刺激或内源性信号的先天免疫反应。在各种病理条件下,中枢神经系统(CNS)会启动有序的先天免疫反应,其中胶质细胞,特别是小胶质细胞会被激活。此外,先天免疫系统已成为慢性疼痛发生和持续治疗控制的一个有前景的靶点。特别是,小胶质细胞对外周和中枢感染、损伤及其他到达CNS的应激信号作出反应,并启动可能导致慢性疼痛易化的CNS免疫激活。在这种有限免疫反应的协调中,小胶质细胞上的TLRs似乎在触发和调节小胶质细胞激活方面最为相关,而这可能是慢性疼痛的驱动力。针对CNS先天免疫系统的新治疗方法可能实现对慢性疼痛的基本药理学控制。